GEOVAX LABS INC Share Price Today: Live Updates & Key Insights

GEOVAX LABS INC share price today is $0.7709, up -12.95%. The stock opened at $0.915 against the previous close of $0.84, with an intraday high of $0.9462 and low of $0.6981.

GEOVAX LABS INC Share Price Chart

GEOVAX LABS INC

us-stock
To Invest in {{usstockname}}
us-stock

GEOVAX LABS INC Share Price Performance

$0.7709 -0.1295(-12.95%) GOVX at 27 Jul 2026 03:21 PM Biotechnology
Lowest Today 0.6981
Highest Today 0.9462
Today’s Open 0.915
Prev. Close 0.84
52 Week High 20.63
52 Week Low 0.69
Day’s Range: Low 0.6981 High 0.9462
52-Week Range: Low 0.69 High 20.63
1 day return -
1 Week return -25.28
1 month return -46.26
3 month return -35.13
6 month return -75.83
1 year return -2.67
3 year return -92.13
5 year return -98.84
10 year return -

GEOVAX LABS INC Institutional Holdings

Armistice Capital, LLC 9.31

Geode Capital Management, LLC 1.25

Fidelity Extended Market Index 0.77

Virtu Financial LLC 0.36

Vanguard Group Inc 0.34

Vanguard Fiduciary Trust Co 0.18

UBS Group AG 0.15

Tower Research Capital LLC 0.12

Vanguard Capital Management, LLC 0.11

Vanguard Institutional Extnd Mkt Idx Tr 0.11

NT Ext Equity Mkt Index Fund - NL 0.10

Northern Trust Extended Eq Market Idx 0.09

NT Ext Equity Mkt Index Fund - Lending 0.09

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.08

BlackRock Inc 0.04

Spartan Extended Market Index Pool F 0.04

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.03

Fidelity Series Total Market Index 0.03

Fidelity Total Market Index 0.02

SBI Securities Co Ltd 0.01

Spartan Total Market Index Pool G 0.01

Blackrock Extended Mkt Fund CF 0.01

Extended Equity Market Fund B 0.01

Extended Equity Market Fund E 0.01

Wells Fargo & Co 0.00

State St US Extended Mkt Indx NL Cl C 0.00

SSgA U.S. Total Market Index Strategy 0.00

Morgan Stanley - Brokerage Accounts 0.00

Caitong International Asset Management Co., Limited. 0.00

Danske Bank A/S. 0.00

Citadel Advisors Llc 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

FMR Inc 0.00

Northern Trust Corp 0.00

Quaker Wealth Management, LLC 0.00

Royal Bank of Canada 0.00

State Street Corp 0.00

GEOVAX LABS INC Market Status

Strong Buy: 3

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

GEOVAX LABS INC Fundamentals

Market Cap 4.38 M

PB Ratio 9.8771

PE Ratio 0.0

Enterprise Value 4.00 M

Total Assets 6.34 M

Volume 423179

GEOVAX LABS INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:81000 0.1M, FY21:385000 0.4M, FY20:1823000 1.8M, FY19:1175896 1.2M

Annual Profit FY23:null 0.0M, FY22:81000 0.1M, FY21:385000 0.4M, FY20:1823000 1.8M, FY19:1175896 1.2M

Annual Net worth FY23:null 0.0M, FY22:-14014561 -14.0M, FY21:-18531479 -18.5M, FY20:-2938344 -2.9M, FY19:-2375124 -2.4M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:852282 0.9M, Q1/2025:1636863 1.6M, Q3/2024:2789484 2.8M

Quarterly Profit Q1/2026:-3903463 -3.9M, Q3/2025:-16802 -0.0M, Q2/2025:852282 0.9M, Q1/2025:1619942 1.6M, Q3/2024:2789484 2.8M

Quarterly Net worth Q1/2026:-5261921 -5.3M, Q3/2025:-6318914 -6.3M, Q2/2025:-5369783 -5.4M, Q1/2025:-5357651 -5.4M, Q3/2024:-5815468 -5.8M

About GEOVAX LABS INC & investment objective

Company Information GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; and the U.S. Department of Defense. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.

Organisation Biotechnology

Employees 19

Industry Biotechnology

CEO Mr. David Alan Dodd

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

GEOVAX LABS INC FAQs

What is the share price of GEOVAX LABS INC today?

The current share price of GEOVAX LABS INC is $0.7709.

Can I buy GEOVAX LABS INC shares in India?

Yes, Indian investors can buy GEOVAX LABS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy GEOVAX LABS INC shares in India?

You can easily invest in GEOVAX LABS INC shares from India by:

Can I buy fractional shares of GEOVAX LABS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of GEOVAX LABS INC?

GEOVAX LABS INC has a market cap of $4.38 M.

In which sector does GEOVAX LABS INC belong?

GEOVAX LABS INC operates in the Biotechnology sector.

What documents are required to invest in GEOVAX LABS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of GEOVAX LABS INC?

The PE ratio of GEOVAX LABS INC is N/A and the PB ratio is 9.88.